Pharmacokinetics, Food Effect, Ketoconazole Interaction, and Safety of JTK‐853, a Novel Nonnucleoside HCV Polymerase Inhibitor, After Ascending Single and Multiple Doses in Healthy Subjects
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.656
Abstract: Pharmacokinetics, safety, and tolerability of JTK‐853, a novel HCV polymerase inhibitor, were evaluated in single and multiple ascending dose (SAD, MAD) studies, with food‐ and ketoconazole‐related effects on exposure to JTK‐853 and its active (CYP3A4… read more here.
Keywords: hcv polymerase; jtk 853; 853 novel; single multiple ... See more keywords